Tech Company Inital Public Offerings
GlobeImmune IPO
GlobeImmune was acquired by . Shares were listed on 7/2/2014.
Transaction Overview
Company Name
Announced On
7/2/2014
Transaction Type
IPO
Amount
$15,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1450 Infinite Dr.
Louisville, CO 80027
USA
Louisville, CO 80027
USA
Phone
Website
Email Address
Overview
GlobeImmune is developing Tarmogen product candidates to treat cancer and infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Rodell
VP - Bus. Development
Kirk Christoffersen
VP - Finance
Jeffrey Dekker
Browse more venture capital transactions:
Prev: 7/2/2014: Terascala venture capital transaction
Next: 7/3/2014: GridPoint venture capital transaction
Share this article
News on VC Transactions
We document all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs